Staff report
The ultrasound devices market will grow at a CAGR of 6.2% during the forecast period 2024-2031, according to DataM Intelligence report.
The report highlighted recent industry developments in the United States, including:
In October 2025, GE HealthCare expanded its U.S. portable ultrasound production with the new Vscan Air SL featuring AI-powered cardiac and lung assessment, partnering with major hospitals to improve point-of-care diagnostics by 22% in emergency departments.
In September 2025, Philips launched the EPIQ Elite ultrasound system with advanced 3D/4D imaging certified for obstetrics, targeting women’s health clinics via e-commerce platforms amid rising demand for high-resolution fetal monitoring.
In August 2025, Butterfly Network introduced the Butterfly iQ3 handheld ultrasound with extended battery life and cloud connectivity, compliant with FDA guidelines and distributed through Amazon for remote and telemedicine applications.
In addition, the report states that “the global ultrasound devices market is thriving” because of surging demand for non-invasive, real-time imaging amid rising chronic diseases, expanding applications in obstetrics, cardiology, radiology, and point-of-care diagnostics, and increasing awareness around early detection and portable solutions. Key trends mentiond in the report include innovation in technologies (e.g., AI-powered image enhancement, wireless handheld probes, 3D/4D imaging), growth in portable and compact formats (point-of-care ultrasound for emergency and rural settings), and increasing adoption in emerging markets (affordable color Doppler for maternal health). The rise of telemedicine, premiumization in advanced imaging, and regulatory pushes for safety and accessibility (FDA 510(k), CE marking) are significantly accelerating market expansion amid shifting healthcare preferences for efficient, cost-effective and high-resolution ultrasound solutions.
The market is moderately consolidated among North American, European, and Asia-Pacific producers, with intense competition in AI integration, portability and image quality.
Precedence Research reports that the global ultrasound market size was calculated at $10.06 billion in 2024 and is predicted to increase from $10.80 billion in 2025 to approximately $20.21 billion by 2034, expanding at a CAGR of 7.23% from 2025 to 2034. The rise in the number of diagnostic centers and hospitals is driving the growth of the ultrasound market.
It also states that the U.S. ultrasound market size was exhibited at $3.30 billion in 2024 and is projected to be worth around $6.78 billion by 2034, growing at a CAGR of 7.47% from 2025 to 2034.
North America dominated the ultrasound market in 2024. The market growth is generally driven by the rising prevalence of target diseases, the growing trend of cosmetic surgeries, and increased healthcare spending by the private and public sectors. Moreover, new research developments and innovations in the medical field, along with new approvals from the United States Food and Drug Administration and the launch of new products by key market players such as Mindray, Butterfly, GE, Medtronic, Siemens and others.
In North America, the U.S. led the market owing to the growing adoption of point-of-care ultrasound along with ongoing technological innovations. Also, heavy private investments in healthcare infrastructure and government funding are major factors contributing to the country’s growth. Major market players in the U.S. are Siemens Healthineers AG, GE HealthCare, Koninklijke Philips N.V., and Canon Medical Systems.
Grand View Research reports that the global ultrasound devices market size was estimated at $9.79 billion in 2023 and is anticipated to reach $13.07 billion by 2030, growing at a CAGR of 4.24% from 2024 to 2030. The market growth is poised to be driven by the rising usage of ultrasound equipment for diagnostic imaging and treatment, along with the increasing prevalence of chronic and lifestyle disorders.
The global point of care ultrasound market was valued at $4.2 billion in 2025 and is projected to grow from $4.5 billion in 2026 to $8.4 billion by 2035, expanding at a CAGR of 7.2%, according to the latest report published by Global Market Insights Inc. The steady growth of the market is driven by the increasing prevalence of chronic diseases, advancements in point-of-care ultrasound technology and a growing geriatric population base.
